laboratorios

Una IA podría reducir hasta un 50% los animales en laboratorios de investigación farmacológica

by

The landscape of pharmacological research is undergoing a significant transformation as emerging technologies offer new ways to refine, reduce, and replace the use of animal models in clinical testing. Recent advancements in artificial intelligence are now being positioned as a powerful tool to accelerate this shift, with researchers exploring how machine learning can potentially cut … Read more

Personalized Vaccination Enhances Protection for Immunocompromised Patients and Those with Comorbidities: Latest Insights from iSanidad

by

Personalized vaccination is emerging as a critical strategy in preventive medicine, particularly for patients with complex health conditions. By tailoring immunization schedules to an individual’s immune status, healthcare providers aim to improve vaccine effectiveness and reduce the risk of vaccine failure. This approach is gaining attention as experts emphasize its importance for older adults, immunocompromised … Read more

>Visionarium Awards Three HIV Innovation Projects

by

AI-Powered System Wins Health Award for Improving HIV Patient Care A new artificial intelligence (AI) system, IA-PROM-VIH, has been recognized for its potential to revolutionize healthcare for individuals living with HIV. The system analyzes Patient-Reported Outcome Measures (PROMs) and Patient-Reported Experience Measures (PREMs) to identify unmet clinical needs,emotional barriers,and hidden risks that may not be … Read more

]Pharmaceutical Innovation Trends: What’s New Now

by

“`html Bexicaserin Shows Promise in Long-Term Treatment of Severe epilepsy Bexicaserin Shows Promise ⁣in‍ Long-Term ⁢treatment of Severe ⁢Epilepsy Published: 2026/01/15 ‍20:02:40 New long-term ‍data presented at the ⁤American ⁢Epilepsy Society (AES) Congress in December 2025 indicates that‍ bexicaserin (LP352), an investigational drug ‍developed by Lundbeck, continues to demonstrate efficacy⁤ in reducing⁢ seizure frequency‍ in … Read more